5 min read
|
Saved February 14, 2026
|
Copied!
Do you care about this?
This article details the Quiet Riot tool for enumerating AWS, Azure, and GCP principals without authentication. It explains setup requirements, command usage, and performance insights based on extensive testing. The tool facilitates automated scanning for various account IDs and user details across cloud services.
If you do, here's more
Quiet Riot is a tool designed for validating AWS, Azure, and GCP principals without authentication. It can enumerate AWS Account IDs, root email addresses, users, roles, Azure AD users, and Google Workspace users. Users need to have sufficient AWS credentials set up via the CLI to run scans, though the tool is primarily unauthenticated. The installation process involves creating a virtual environment or simply installing the package with pip, followed by executing commands to specify scan types and parameters.
The tool allows for various scan types, including AWS Account IDs and Microsoft 365 Domains, with a required argument for scan type. Users can also specify the number of threads to run (with a suggested maximum around 700) and provide a path to a wordlist file. The author conducted extensive performance tests and found that the biggest limitation is I/O capacity in single-threaded Python applications. By implementing multi-threading, the tool can make around 1100 API calls per second, though it's important to note that throttling by AWS APIs can lead to exceptions during scans.
Enumerating all possible AWS Account IDs would take an impractical amount of time using a single account, estimated at over 28 years. However, by creating multiple AWS accounts and optimizing the scanning process, this time can be drastically reduced. The article highlights that while thereβs an initial limit of 20 accounts per AWS organization, this limit can be increased with approval from AWS, allowing for more efficient scanning. The toolβs capabilities span numerous AWS services, though many API limits and resource pricing details remain unknown.
Questions about this article
No questions yet.